In this episode, Hall welcomes Dr. Orrin Ailloni-Charas of RedCrow, a healthcare-focused, early-stage startup investing network. Orrin’s background in medicine led to consulting roles with various healthcare startups. He received his MBA from Columbia, and now has a career straddling both the business world and medial and clinical world.
Orrin explains how RedCrow incorporates crown-based evaluation and analysis to fully validate startups. Orrin talks about the environment of innovation in healthcare. He explains some of the advantages and challenges of investing in healthcare, and the importance of understanding the startup’s competitive, regulatory, and capital risks. For healthcare startups, Orrin emphasizes the importance of good IP with strong protections. He also talks about the advantages of good partners, and how capital risk is a particular risk in the healthcare industry.
You can find RedCrow at redcrow.com
Orrin can be reached on LinkedIn at linkedin.com/in/orrin-ailloni-charas-md-2975a
Copyright (c) 2021, Hall Martin and investorconnect.org. All rights reserved.
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.